VitMode

Andropause

A gradual decline in testosterone in middle-aged and older men, far milder than menopause — a real physiological phenomenon, but one that requires intervention less often than the popular understanding of the term suggests.

PZdr Piotr ZielińskiReviewed by dr Anna KowalczykUpdated: August 3, 2026
Moderate evidence
4.5

Number of studies

1

Safety

Moderate

Time to effects

Not applicable — a gradual process spread over decades, not a single-point intervention.

Who it's for

Middle-aged and older men with symptoms suggesting testosterone deficiencyMen wanting to understand the natural course of hormonal changes with age
Table of contents

TL;DR

A gradual decline in testosterone in middle-aged and older men, far milder than menopause — a real physiological phenomenon, but one that requires intervention less often than the popular understanding of the term suggests.

  • Understanding the mechanism helps distinguish natural aging from a real, attention-worthy hormonal deficiency
  • Points to modifiable factors (sleep, body weight, stress) that can be addressed before considering hormone therapy
  • Established diagnostic criteria (EMAS) prevent overdiagnosis and unnecessary medicalization
Intervention typeAge-related physiological process, not a single intervention
Research levelModerate — the mechanism is well understood, diagnostic criteria established in large cohort studies
Target groupMiddle-aged and older men with symptoms of testosterone deficiency
Time to effectsNot applicable — a gradual process spread over decades
Preparation requiredMorning testosterone, LH, and FSH testing if symptomatic deficiency is suspected
StatusNatural physiological process, partly modifiable through lifestyle

Understand

Overview

Andropause is a colloquial term describing the gradual decline in testosterone levels in men with age, typically by about 1–2% per year after age 30–40. Unlike menopause in women, where the drop in estrogen is abrupt and occurs within a defined, relatively short window, the decline in testosterone in men is much gentler, spread out over decades, and does not affect all men to the same degree.

A large European cohort study (the European Male Ageing Study) established precise criteria for diagnosing so-called late-onset hypogonadism — the combination of low testosterone with specific sexual symptoms (reduced libido, erectile dysfunction, fewer morning erections) — showing that a decline in testosterone alone, without these symptoms, should not automatically be treated as a condition requiring treatment.

Who can realistically benefit from this? Middle-aged and older men experiencing real symptoms (not just a natural, asymptomatic decline in testosterone) — for them, understanding andropause as a gradual process, partly modifiable through lifestyle, helps avoid both dismissing genuine symptoms and unnecessarily medicalizing natural aging.

Mechanism of action

The decline in testosterone with age results from several overlapping processes: a gradual reduction in the number and sensitivity of testosterone-producing Leydig cells in the testes, an increase in sex hormone-binding globulin (SHBG), which limits the amount of biologically active free testosterone, and a mild weakening of signaling along the hypothalamic-pituitary axis with age.

These processes also overlap with modifiable lifestyle factors — an increase in body fat (which aromatizes testosterone into estrogen), worsening sleep quality, and mounting chronic stress, all of which lower testosterone independently of biological age. This is why part of the decline attributed to andropause is, in practice, sometimes the result of accumulated lifestyle factors rather than aging alone.

1

Reduction in Leydig cell number

With age, the number and sensitivity of the testicular cells responsible for testosterone production decreases.

2

Rise in SHBG

Rising sex hormone-binding globulin levels with age limit the amount of biologically active free testosterone.

3

Mild weakening of the hypothalamic-pituitary axis

The hormonal signaling that drives testosterone production weakens slightly with age.

4

Overlapping lifestyle factors

Increased body fat, poorer sleep, and chronic stress further lower testosterone independently of age itself.

Evidence: moderate — based on 1 study in this database.

Benefits

Understanding the mechanism helps distinguish natural aging from a real, attention-worthy hormonal deficiency
Points to modifiable factors (sleep, body weight, stress) that can be addressed before considering hormone therapy
Established diagnostic criteria (EMAS) prevent overdiagnosis and unnecessary medicalization

Common myths

MythAndropause is the male equivalent of menopause, with a similarly abrupt course.

FactThe decline in testosterone in men is far gentler and more drawn out over time than the decline in estrogen in women during menopause — this is a qualitatively different process.

MythEvery aging man with lower testosterone has andropause requiring treatment.

FactDiagnosis requires the co-occurrence of low testosterone and specific sexual symptoms — an age-related decline alone, without symptoms, does not meet clinical criteria.

Practice

Frequently asked questions

The gradual decline in testosterone usually begins after age 30–40, but the pace and severity of symptoms vary widely between individuals.

No — only the co-occurrence of low testosterone and real symptoms justifies considering therapy, and part of the decline can sometimes be reversed through lifestyle changes.

Andropause symptoms are nonspecific, so diagnosis requires testing testosterone levels and ruling out other causes (hypothyroidism, depression, sleep apnea) before attributing symptoms to age alone.

Dosage & timing

Typical dose

Not applicable — a physiological process, not a dosed intervention

Form

Diagnostics: morning total testosterone, free testosterone, SHBG, LH, FSH if symptomatic deficiency is suspected

Diagnosis requires the co-occurrence of low testosterone and specific symptoms — not age alone or a single borderline result.

Best times to take it

  • Testosterone testing should always be done in the morning, due to the diurnal rhythm of secretion

Safety

Side effects & contraindications

Possible side effects

Not applicable — this entry describes a physiological process, not an intervention

Contraindications

Not applicable

Interactions

Not directly applicable — see the TRT entry regarding potential interactions of hormone therapy, if pursued

Is it worth taking?

Who it's for

  • Middle-aged and older men with symptoms suggesting testosterone deficiency
  • Men wanting to understand the natural course of hormonal changes with age

Not for

  • Not applicable

Evidence

Worth knowing

The European Male Ageing Study (EMAS) is one of the largest cohort studies to establish criteria for diagnosing late-onset hypogonadism.

Testosterone in men typically declines by about 1–2% per year after age 30–40 — a much slower pace than the popular notion of 'male menopause' suggests.

Studies

Late-onset hypogonadism should only be diagnosed when low testosterone co-occurs with specific sexual symptoms — an age-related decline in the hormone level alone, without these symptoms, does not meet the diagnostic criteria.

Wu FC et al. (European Male Ageing Study), New England Journal of Medicine, 2010

Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men

Strong evidence

Wu FC, Tajar A, Beynon JM, et al. · New England Journal of Medicine · 2010

A large European cohort study (EMAS) establishing criteria for diagnosing late-onset hypogonadism based on the co-occurrence of low testosterone and specific sexual symptoms.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

PZ

Author

dr Piotr Zieliński

Endocrinologist

Piotr reviews content on hormones, metabolic health and supplement pharmacology.

131 publications on this site

AK

Medical review

dr Anna Kowalczyk

Editor-in-Chief, Molecular Biology

Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.

50 publications on this site

Published: August 3, 2026Updated: August 3, 2026

Related entries

Umięśniony sportowiec w stroju treningowym4.7

Testosterone

The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.

HormonyStrong evidence
Strzykawka i leki na jasnej powierzchni4.4

TRT — Administration Forms: Injections, Gels, and Patches

Injections, transdermal gels, and patches — the three main forms of testosterone replacement therapy differ in blood-concentration profile, ease of use, and the risk of transferring the hormone to other people.

TRTStrong evidence
Lekarz w fartuchu analizujący dokumentację medyczną na korytarzu szpitala4.6

Hypogonadism — Diagnosis and Criteria for TRT Eligibility

Not every low testosterone result means hypogonadism requiring treatment. We explain which laboratory and symptomatic criteria must be met before TRT becomes a justified option.

TRTStrong evidence
Lekarz mierzący ciśnienie krwi pacjenta w gabinecie4.7

TRT — Side Effects and Therapy Monitoring

Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.

TRTStrong evidence
Lekarz w białym fartuchu podczas konsultacji medycznej online4.7

TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?

TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.

TRTModerate evidence
Próbki krwi w probówkach na jasnym tle laboratoryjnym4.7

What Tests Are Needed Before TRT? The Complete Pre-Treatment Testing List

Before a physician can qualify a patient for testosterone therapy, a far broader panel of tests is needed than testosterone level alone. The full list of blood tests, symptom questionnaires, and criteria that determine whether TRT is safe and appropriate.

TRTStrong evidence
Lekarz robiący notatki podczas konsultacji medycznej4.7

How Often to Test Testosterone on TRT? Monitoring Schedule and Checkups

Starting testosterone therapy isn't the end of diagnostics — it's the start of a new, recurring rhythm of checkups. We explain which tests happen at month 3, which at year one, and which need repeating for as long as therapy continues — and how the schedule differs between injectable and gel forms.

TRTStrong evidence
Graficzna wizualizacja zapisu pracy serca EKG4.7

TRT and Your Heart — Does Testosterone Therapy Raise Heart Attack Risk?

For a decade, testosterone therapy operated under the shadow of an FDA warning about heart attack risk. The large randomized TRAVERSE trial from 2023 finally gave a clear answer — though not as simple as the headlines suggested. We walk through the whole story, from controversial observational studies to where the evidence stands today.

TRTStrong evidence

Related articles

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.